SAN DIEGO, May 24, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (or the “Company”) AMAM, today announced that it has entered into a securities purchase agreement with clients managed by Darwin Global Management Ltd. (“Darwin”) for the sale of an aggregate of approximately 5.4 million American Depositary Shares…Read More
Ambrx Announces 75 Million Market Priced Registered Offering Ambrx Biopharma NASDAQAMAM
